ANTIHYPERGLYCEMIC MEDICATION PRESCRIBING AND STATE MEDICAID PROGRAM RESPONSES TO ROSIGLITAZONE SAFETY WARNINGS

Medicaid programs use preferred drug lists to limit high-cost prescribing, but their effect on promoting more effective and safer prescribing is unknown. We examined the impact of the May 2007 rosiglitazone safety warnings on rosiglitazone availability on state Medicaid preferred drug list programs...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Ross, Joseph S., Jackevicius, Cynthia A., Krumholz, Harlan M., Ridgeway, Jennifer L., Montori, Victor M., Alexander, G. Caleb, Zerzan, Judy T., Fan, Jiaquan, Shah, Nilay D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2012
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3319744/
https://ncbi.nlm.nih.gov/pubmed/22232110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1377/hlthaff.2011.1068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller